Blazing the Trail for Better Specialty Drug Management by Steve Cutts August 19, 2021Magellan Rx Medical Pharmacy Trend Report, Specialty Pharmacy
Top 10 Takeaways from the 2020 Pharmacy Trend Report by Magellan Rx Management June 9, 2021Biosimilars, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, Magellan Rx Medical Pharmacy Trend Report, medical drug claim, Medical Pharmacy Spend, medical specialty drugs, Medicare, Oncology, Oncology Spend, PMPM, specialty drugs
The Future of Care for Oncology Patients by Rebecca Borgert April 1, 2021Cancer, Cancer treatment, Genomic Testing, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, Oncology, Oncology Care, precision medicine, Precision Medicine in Oncology
2020 FDA Approvals: A Year in Review by Lara Frick March 15, 2021CDER, Center for Drug Evaluation and Research, FDA, FDA Approvals, Food and Drug Administration, Magellan Health, Magellan RX, Magellan Rx Management, New Drugs, Novel agents, Novel drugs, Orphan Drugs
5 Ways to Improve Medication Adherence by Melody DiMaio February 9, 2021Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, medication adherence, Medications, Prescriptions, Social Determinants of Health
Accreditations and their Industry Value by Magellan Rx Management October 29, 2020Accreditations, Healthcare Organizations, Magellan, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, quality
Alternative Cost-Saving Strategies for Innovative Treatments: Will Medicaid Enter the Value-Based Pricing Market? by Lara Frick September 23, 2020Magellan Health, Magellan RX, Magellan Rx Management, Medicaid, Novel Medications, Outcome Based Pricing, Specialty Pharmacy Trend Alert, Trend Alert, Value Based Purchasing
The Future is Now: The 17th Annual Specialty Summit by Magellan Rx Management September 11, 2020Biosimilars, COVID-19, Future of Genomics, Future of Specialty Pharmacy, Magellan, Magellan Health, Magellan RX, Magellan Rx Management, Magellan Rx Management Specialty Summit, MRx Specialty Summit, Oncology Biosimilars, Precision Medicine in Oncology, specialty drugs
